Why Pharma Collaboration is Reshaping Disease Modeling in 2025
Drug development faces a significant challenge: 28% of medications leave the US market because of unexpected heart-related side effects. This stark reality, combined with 400 million people worldwide affected by rare diseases, makes pharmaceutical collaboration more vital than ever. Pharmaceutical companies are reshaping their approach...
February 19, 2025